Medicina
Departamento
Universidad de Zaragoza
Zaragoza, EspañaPublicaciones en colaboración con investigadoras/es de Universidad de Zaragoza (28)
2024
-
Indications of Helicobacter pylori Eradication Treatment and Its Influence on Prescriptions and Effectiveness (Hp-EuReg)
Helicobacter, Vol. 29, Núm. 4
2023
-
Author Correction: Comparison of the management of Helicobacter pylori infection between the older and younger European populations (Scientific Reports, (2023), 13, 1, (17235), 10.1038/s41598-023-43287-4)
Scientific Reports
-
Comparison of the management of Helicobacter pylori infection between the older and younger European populations
Scientific Reports, Vol. 13, Núm. 1
2022
2020
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort
Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552
2018
-
Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox
United European Gastroenterology Journal, Vol. 6, Núm. 4, pp. 622-629
-
Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding
Gastroenterologia y Hepatologia
2017
-
Effectiveness of a simple intervention on management of acute exacerbations of chronic obstructive pulmonary disease and its cardiovascular comorbidities: COREPOC study
Medicina Clinica, Vol. 149, Núm. 6, pp. 240-247
-
Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype
Oncotarget, Vol. 8, Núm. 22, pp. 35848-35862
2016
-
Endoscopist characteristics that influence the quality of colonoscopy
Endoscopy, Vol. 48, Núm. 3, pp. 241-247
-
Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening
Digestive and Liver Disease, Vol. 48, Núm. 5, pp. 542-551
2015
-
Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease
International Journal of Cancer, Vol. 137, Núm. 6, pp. 1362-1373
-
Reply
Clinical Gastroenterology and Hepatology
-
Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants
Clinical Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 906-912.e2
2014
-
Effect of oral anticoagulants on the outcome of faecal immunochemical test
British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337
-
Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high-or low-risk stigmata
Scandinavian Journal of Gastroenterology, Vol. 49, Núm. 10, pp. 1181-1190
-
Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening
Cancer Causes and Control, Vol. 25, Núm. 8, pp. 985-997
2013
-
Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test
Mayo Clinic Proceedings
-
Effect of proton pump inhibitors on the outcomes of peptic ulcer bleeding: Comparison of event rates in routine clinical practice and a clinical trial
Scandinavian Journal of Gastroenterology, Vol. 48, Núm. 3, pp. 285-294
-
Modifiable endoscopic factors that influence the adenoma detection rate in colorectal cancer screening colonoscopies
Gastrointestinal Endoscopy, Vol. 77, Núm. 3